Now it is mRNA Flu Shots By Brian Simpson
Why should we continue to be concerned about the mRNA vaccines? Hasn’t the Covid issue now finished, apart from the injuries, and deaths? Well, no, not so. Now we have the push for mRNA flu shots, which apparently work on the same method that the Covid mRNA vaxxes work. You see the demand for the mRNA vaxxes is on the down curve and a new money spinner is needed, and naturally enough, Big Pharma-dominated governments look like getting right behind this yet again.
No matter that a healthy immune system, vitamin D3 and C, would protest most individuals. No, once more, it is time to panic. The flu is coming. I don’t know about you, but all this has given me a case of viral fatigue, big time.
https://armageddonprose.substack.com/p/techno-hell-pfizer-mrna-shots-soon
“The benevolent multinational technocratic overlords at Pfizer, assisted of course by the magnanimous Public Health™ authorities in the United States and throughout the West, are excited to introduce mRNA flu shots, seeing as how the mRNA COVID-19 injections have performed so admirably over the past two and a half years.
Via Pfizer:
"In September 2022, Pfizer began recruiting volunteers to participate in its Phase 3 clinical trial for that mRNA flu vaccine candidate. The hope, says McLaughlin, is that scientists can develop a flu vaccine faster, and with more accurate strain matching with in-season circulating strains than those currently available. One that may also spark a more robust immune response.
“As these viruses continue to adapt, what really matters is how well your vaccine matches what strains are currently circulating,” says McLaughlin. “And the speed with which you can keep up with that determines the success of a vaccination program.”"
Eerily reminiscent of "Operation Warp Speed," no?
The National Institutes of Health bureaucrats are also eager beavers to get their biotech into the arms of every American man, woman, child, and baby. Because they care.
Via NIH:
"A clinical trial of an experimental universal influenza vaccine developed by researchers at the National Institute of Allergy and Infectious Diseases’ (NIAID) Vaccine Research Center (VRC), part of the National Institutes of Health, has begun enrolling volunteers at Duke University in Durham, North Carolina. This Phase 1 trial will test the experimental vaccine, known as H1ssF-3928 mRNA-LNP, for safety and its ability to induce an immune response."
Here is … Pfizer CEO Albert Bourla predicting this new technology will be available for deployment by flu season 2023.
To the non-immunocompromised, of course -- an inconvenient truth, so to speak, for all of the biomedical profiteers -- the flu presents no real risk. A strong immune system, as conferred by proper eating habits, exercising, and vitamin D exposure, is well enough to combat the flu.
But, then again, non-patentable vitamin D from the sun is not going to generate executive bonuses or hearty kickbacks to NIH bureaucrats, now is it?”
Comments